• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway m

tetano

Editor, Senior Moderator
Front Immunol


. 2026 Mar 13:17:1768280.
doi: 10.3389/fimmu.2026.1768280. eCollection 2026.
Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway mucins in a subtype-dependent manner

John Benktander[SUP] 1 [/SUP], Macarena Paz Quintana Hayashi[SUP] 1 [/SUP], Rickard Nordén[SUP] 2 3 [/SUP], Lisa Pettersson[SUP] 4 [/SUP], Magnus Paulsson[SUP] 5 6 [/SUP], Anders Lindén[SUP] 7 8 [/SUP], Sara K Lindén[SUP] 1 [/SUP]


Affiliations
Abstract

Background: Influenza infection increases the risk of pneumonia and respiratory failure in chronic obstructive pulmonary disease (COPD) and mucins play an important role in pulmonary host defense.
Methods: Lower airway mucins were obtained from long-term smokers with and without COPD, pneumonia patients, and healthy never-smokers; oral MUC5B was obtained from a healthy never-smoker, and the ability of lower airway mucins and oral MUC5B to bind influenza A virus (H1N1 and H3N2) was investigated.
Results: Lower airway mucins from long-term smokers with and without COPD, as well as the oral MUC5B, bound to H1N1. In contrast, all mucins, regardless of donors, bound to H3N2. Differences in binding were linked to more pronounced glycan sialylation in lower airway mucins from pneumonia patients and long-term smokers compared with healthy never-smokers. For lower airway mucins, the abundance of α2-6-linked NeuAc correlated with H1N1 binding, whereas the abundance of α2-3-linked NeuAc correlated with H3N2 binding. A neuraminidase inhibitor increased virus binding, even more so for H1N1 than for H3N2, resulting in the binding of both H1N1 and H3N2 to all mucins. The H1N1 neuraminidase cleaved α2-3- and α2-6-linked NeuAc to a similar degree, whereas the H3N2 neuraminidase mainly cleaved the α2-6-linked NeuAc. Mucins inhibited influenza A infection in a concentration-dependent manner in airway epithelial cells, although more so for H1N1 than for H3N2.
Conclusion: Mucins inhibit influenza infection, and this effect depends on viral subtype. Neuraminidase inhibitors enable mucins with low sialic acid content to preserve their virus-binding ability, thereby underscoring their therapeutic potential.

Keywords: BAL; O-glycan; influenza A virus; inhibition; lung; mucins.

 
Back
Top